Nothing will happen with the PPS until some great news comes out. Either in the form of increased revs beyond the $5M for 2016 or Fluticare approval. The longer it takes, the lower the stock will go.
Potentially we could see Fluticare be approved first in EU and hopefully followed by US.
I don't expect to see anything significant in revenues until end of Q1.
There will be a dip in the stock towards end of OCT without Fluticare approval.
Market Data 
Markets 
AI
